Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
第一作者:
Julie,Irving
第一单位:
Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom;
作者:
主题词
动物(Animals);苯咪唑类(Benzimidazoles);细胞系, 肿瘤(Cell Line, Tumor);儿童(Child);临床试验(主题)(Clinical Trials as Topic);抗药性, 肿瘤(Drug Resistance, Neoplasm);基因频率(Gene Frequency);基因, ras(Genes, ras);人类(Humans);MAP激酶激酶激酶类(MAP Kinase Kinase Kinases);小鼠(Mice);小鼠, 近交NOD(Mice, Inbred NOD);小鼠, SCID(Mice, SCID);小鼠, 转基因(Mice, Transgenic);突变(Mutation);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);蛋白激酶抑制剂(Protein Kinase Inhibitors);复发(Recurrence);信号传导(Signal Transduction);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1182/blood-2014-04-531871
PMID
25253770
发布时间
2022-04-10
- 浏览69

Blood
3420-30页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文